Conmed Corp (CNMD) Misses Q2 EPS by 2c; Lowers FY12 Sales Outlook; Guides Q3
Tweet Send to a Friend
Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.43, $0.02 worse than the analyst estimate of $0.45. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
